Eli Lilly (LLY) Targets Black-Market Sales of Unapproved Weight-Loss Drug in Legal Battle
Key Highlights Pharmaceutical giant Eli Lilly has initiated legal proceedings against six American businesses distributing unauthorized versions of retatrutide, its investigational obesity tr

